TAM-derived exosomal miR-125a/b, miR-142, and miR-223 control the expression of cancer-stem-cell-associated genes like CD90 that boost tumor recurrence and resistance in HCC (174). This evidence concerns the gene THY1 and hepatocellular carcinoma.